The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 USD | +6.15% | +18.75% | +37.58% |
The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.41 AUD | +0.71% | +0.36% | 158M | ||
0.19 USD | +6.15% | +18.75% | 33.19M | ||
1st Jan change | Capi. | |
---|---|---|
+37.58% | 33.19M | |
+20.07% | 43.95B | |
+22.22% | 22.49B | |
+13.86% | 14.71B | |
+10.64% | 13.77B | |
+40.61% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |